Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples